Fordesia
Fordesia contains Donepezil HCl, an acetylcholinesterase inhibitor from piperidine class that reversibly inhibits acetylcholinesterase enzyme. It is indicated as symptomatic treatment of mild to moderate dementia in Alzheimer’s disease.
Donepezil HCl increases cholinergic function by increasing acetylcholine concentration through inhibition of acetylcholine hydrolysis by acetylcholinesterase.
Composition
Each tablet contains Donepezil HCl 5 mg
Indication
Symptomatic treatment of mild to moderate dementia in Alzheimer’s disease
Symptomatic treatment of mild to moderate dementia in Alzheimer’s disease
Contra Indication
Patients who are hypersensitive to Donepezil HCl, Piperidin derivative, or to other component in Fordesia
Patients who are hypersensitive to Donepezil HCl, Piperidin derivative, or to other component in Fordesia
Warning
• Supraventricular cardiac conduction disorders
• History of ulcer disease, asthma, NSAID therapy
• Supraventricular cardiac conduction disorders
• History of ulcer disease, asthma, NSAID therapy
Adverse Reaction
Diarrhea, muscle cramps, fatigue, nausea, vomiting, insomnia, dizziness, psychiatric disturbances
Diarrhea, muscle cramps, fatigue, nausea, vomiting, insomnia, dizziness, psychiatric disturbances
Dosage
5 mg daily
Dosage may be increased to 10 mg daily following 1 mounth clinical assessment
5 mg daily
Dosage may be increased to 10 mg daily following 1 mounth clinical assessment
Presentation
Box / 3 strip @ 10 tablets
Box / 3 strip @ 10 tablets
Calendar of Events
|